https://www.biospace.com/regenxbio-announces-presentation-at-the-virtual-svb-securities-global-biopharma-conference
REGENXBIO Announces Presentation at the Virtual SVB Securities Global Biopharma Conference -...
Feb 8, 2023 - REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will present at the SVB Securities Global Biopharma Conference on Thursday, February 16, 2023.
the virtualsvb securitiesannouncespresentation
https://www.businesswire.com/news/home/20230131005510/en/Aptinyx-to-Present-at-the-SVB-Securities-Global-Biopharma-Conference
Aptinyx to Present at the SVB Securities Global Biopharma Conference
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system dis...
svb securitiespresentglobalbiopharmaconference
https://www.businesstimes.com.sg/companies-markets/fdic-retains-blackrock-unit-signature-bank-svb-securities-portfolio-sale
FDIC retains BlackRock unit for Signature Bank, SVB securities portfolio sale - The Business Times
THE Federal Deposit Insurance Corporation (FDIC) has retained BlackRock unit Financial Market Advisory to sell the securities portfolios it kept in...